Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Evotec and Genentech enter agreement to discover small-molecule therapeutics

May 11, 2010

Alzheimer's Drug Discovery Foundation funds chaperone technology

May 10, 2010

Meda acquires exclusive rights to flupirtine for fibromyalgia

May 10, 2010

Polyphor enters into PEMfinder collaboration with Novartis

May 10, 2010

Stemgent and Miltenyi Biotec form strategic stem cell partnership

May 10, 2010

Intercell acquires monoclonal antibody discovery platform from Cytos

May 10, 2010

Boehringer Ingelheim and Micromet collaborate for multiple myeloma antibody

May 7, 2010

S*BIO and Onyx expand collaboration agreement for JAK2 inhibitors

May 6, 2010

TB Alliance and AstraZeneca enter collaboration agreement for TB drug discovery and development

May 5, 2010

Targacept and AstraZeneca amend agreement to expand TC-5619 development program

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.